The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

43 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
171
Perk inhibiting compoundsBDB
Hibercell
84
SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOFBDB
Sanofi
108
3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOFBDB
BeiGene
37
ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOFBDB
Regeneron Pharmaceuticals
417
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofBDB
Genentech
1
CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDEBDB
Bayer Aktiengesellschaft
162
Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereofBDB
280 Bio
253
Imino sulfanone inhibitors of ENPP1BDB
Volastra Therapeutics
64
Therapeutic agent for non-motor symptoms associated with Parkinson's diseaseBDB
Sumitomo Pharma
52
Imidazole and triazole containing bicyclic compounds as JAK inhibitorsBDB
Theravance Biopharma R&D Ip
780
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsBDB
Forma Therapeutics
61
Macrocyclic compounds that inhibit MCL-1 proteinBDB
Amgen
11
Fused imidazo-piperidine JAK inhibitorsBDB
Theravance Biopharma R&D Ip
223
Macrocyclic compounds for treatment of medical disordersBDB
Achillion Pharmaceuticals
129
CXCR7 antagonistsBDB
Chemocentryx
11
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBDB
Bristol Myers Squibb
110
Oxadiazolones as transient receptor potential channel inhibitorsBDB
Genentech
19
Epoxyketone compounds for enzyme inhibitionBDB
Centrax International
26
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofBDB
Guangzhou Maxinovel Pharmaceuticals
9
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofBDB
Santen Pharmaceutical
20
Pyrrolo[2,3-d]pyrimidine compound or salt thereofBDB
Taiho Pharmaceutical
369
Metallo-beta-lactamase inhibitorsBDB
Merck Sharp & Dohme
115
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitorsBDB
Bristol Myers Squibb
116
Protein kinase C inhibitors and methods of their useBDB
Novartis
57
Alpha-carbolines for the treatment of cancerBDB
Universita Degli Studi Di Milano—Bicocca
177
Indole and indazole compounds that activate AMPKBDB
Pfizer
11
Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.BDB
Ondokuz Mayis University
34
Bicyclic substituted pyrimidine compoundsBDB
Xuanzhu Pharma
82
Compositions and methods for the treatment of malariaBDB
Saint Louis University
29
5-HT3 receptor antagonistsBDB
Takeda Pharmaceutical
5
Optically pure benzyl-4-chlorophenyl-C-glucoside derivativeBDB
Xuanzhu Pharma
22
Triazolopyridinone PDE10 inhibitorsBDB
Merck Sharp & Dohme
12
Functional reversal of (-)-Stepholidine analogues by replacement of benzazepine substructure using the ring-expansion strategy.BDB
Fudan University
23
Tricyclic heterocyclic compoundsBDB
Bristol Myers Squibb
5
Compounds and methods for purification of serine proteasesBDB
Portola Pharmaceuticals
22
Inhibition of memapsin 1 cleavage in the treatment of diabetesBDB
Oklahoma Medical Research Foundation
28
Selective caspase inhibitors and uses thereofBDB
Novagenesis Foundation
20
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.BDB
The M. S. University of Baroda
10
Pyridinedione carboxamide inhibitors of endothelial lipaseBDB
Bristol Myers Squibb
111
Aminopyrazole derivativeBDB
Chugai Seiyaku Kabushiki Kaisha
5
Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profileBDB
Abbvie
8
Photoaffinity labeling of the Ah receptor.BDB
University of Wisconsin
16
Somatostatin and its receptor family.BDB
Royal Victoria Hospital